Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- CheckyesterdayChange DetectedA new revision (v3.7.0) is added to the record history, introducing entries for Find contact information, Contacts/Locations, and Study Status, dated 2026-09-15 to 2026-09-18, while an older revision (v3.6.6) is removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page history shows a new revision entry (v3.6.6) with added sections for Contacts/Locations and Study Status, and the preceding revision (v3.6.5) was removed. This reflects an update to the history-tracking UI and versioning metadata rather than substantive study data changes.SummaryDifference0.1%

- Check29 days agoChange DetectedRecent history entries document updated Study Status and Contacts/Locations for August 2026 (versions 256–258), with an older August 13 entry removed.SummaryDifference0.2%

- Check37 days agoChange DetectedNew history entries were added for versions 254 (2026-08-07) and 255 (2026-08-12), and the 2026-08-13 update adds the Study Status and Contacts/Locations sections to the record history; an earlier entry from 2026-08-05 was removed.SummaryDifference0.1%

- Check44 days agoChange DetectedVersion 3.6.5 was added on 2026-08-05, introducing updates to the Study Status and Contacts/Locations sections. The history also records **Revision: v3.6.5** and removes the prior **Revision: v3.6.4** entry.SummaryDifference0.2%

- Check51 days agoChange DetectedThe latest version updates the study title to 'Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)' and adds key sections (Contacts/Locations, Eligibility, Study Status, Study Identification). It also removes the previous title entry from 2026-07-16.SummaryDifference0.1%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.